TSHA logo

Taysha Gene Therapies (TSHA) Enterprise Value

Enterprise Value

$262.48 M
+$7.17 M+2.81%

9 min ago


Summary


Performance

TSHA Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherTSHAvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

TSHA Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+2.8%+2.0%+2.0%
1 m1 month-10.7%-8.1%-8.1%
3 m3 months+27.3%+18.7%+18.7%
6 m6 months-6.8%-9.8%-11.4%
ytdytd+3.6%+2.6%+2.6%
1 y1 year+31.6%+26.7%+15.6%
5 y5 years---

TSHA Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-20.2%$212 M+23.8%
3 m3-month$575 M-54.4%$186 M+41.5%
6 m6-month$575 M-54.4%$167 M+57.0%
1 y1-year$720 M-63.6%$167 M+57.0%
3 y3-year$720 M-63.6%$15 M+1625.7%
5 y5-year$948 M-72.3%$15 M+1625.7%
alltimeall time$948 M-72.3%$15 M+1625.7%

Taysha Gene Therapies Enterprise Value History

DateValue
2025
$262.48 M(+3.6%)
2024
$253.25 M(+0.6%)
2023
$251.79 M(+121.6%)
DateValue
2022
$113.63 M(-68.6%)
2021
$362.21 M(-51.8%)
2020
$750.93 M

FAQ

  • What is Taysha Gene Therapies enterprise value?
  • What is the all time high enterprise value for Taysha Gene Therapies?
  • What is TSHA enterprise value year-to-date change?
  • What is Taysha Gene Therapies enterprise value year-on-year change?

What is Taysha Gene Therapies enterprise value?

The current enterprise value of TSHA is $262.48 M

What is the all time high enterprise value for Taysha Gene Therapies?

Taysha Gene Therapies all-time high enterprise value is $947.67 M

What is TSHA enterprise value year-to-date change?

Taysha Gene Therapies enterprise value has changed by +$9.22 M (+3.64%) since the beginning of the year

What is Taysha Gene Therapies enterprise value year-on-year change?

Over the past year, TSHA enterprise value has changed by +$63.00 M (+31.58%)